AIMD
Price
$1.43
Change
-$0.02 (-1.38%)
Updated
Aug 21 closing price
Capitalization
10.56M
Intraday BUY SELL Signals
MBOT
Price
$1.50
Change
+$0.01 (+0.67%)
Updated
Aug 21 closing price
Capitalization
100.75M
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AIMD vs MBOT

AIMD vs MBOT Comparison Chart in %
View a ticker or compare two or three
VS
AIMD vs. MBOT commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIMD is a Hold and MBOT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (AIMD: $1.43 vs. MBOT: $1.50)
Brand notoriety: AIMD and MBOT are both not notable
AIMD represents the Electronic Equipment/Instruments, while MBOT is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AIMD: 32% vs. MBOT: 43%
Market capitalization -- AIMD: $10.56M vs. MBOT: $100.75M
AIMD [@Electronic Equipment/Instruments] is valued at $10.56M. MBOT’s [@Medical/Nursing Services] market capitalization is $100.75M. The market cap for tickers in the [@Electronic Equipment/Instruments] industry ranges from $122.53B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $201.83B to $0. The average market capitalization across the [@Electronic Equipment/Instruments] industry is $8.9B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIMD’s FA Score shows that 0 FA rating(s) are green whileMBOT’s FA Score has 0 green FA rating(s).

  • AIMD’s FA Score: 0 green, 5 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, MBOT is a better buy in the long-term than AIMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIMD’s TA Score shows that 5 TA indicator(s) are bullish while MBOT’s TA Score has 4 bullish TA indicator(s).

  • AIMD’s TA Score: 5 bullish, 3 bearish.
  • MBOT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AIMD is a better buy in the short-term than MBOT.

Price Growth

AIMD (@Electronic Equipment/Instruments) experienced а +0.70% price change this week, while MBOT (@Medical/Nursing Services) price change was -3.23% for the same time period.

The average weekly price growth across all stocks in the @Electronic Equipment/Instruments industry was -3.36%. For the same industry, the average monthly price growth was +2.87%, and the average quarterly price growth was -1.10%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.94%. For the same industry, the average monthly price growth was +6.51%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

MBOT is expected to report earnings on Aug 24, 2026.

Industries' Descriptions

@Electronic Equipment/Instruments (-3.36% weekly)

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

@Medical/Nursing Services (-0.94% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBOT($101M) has a higher market cap than AIMD($10.6M). AIMD YTD gains are higher at: -12.805 vs. MBOT (-25.000). AIMD has higher annual earnings (EBITDA): -8.46M vs. MBOT (-16M). MBOT has more cash in the bank: 72.5M vs. AIMD (2.84M). MBOT has less debt than AIMD: MBOT (898K) vs AIMD (13.8M). MBOT has higher revenues than AIMD: MBOT (105K) vs AIMD (18.1K).
AIMDMBOTAIMD / MBOT
Capitalization10.6M101M10%
EBITDA-8.46M-16M53%
Gain YTD-12.805-25.00051%
P/E RatioN/AN/A-
Revenue18.1K105K17%
Total Cash2.84M72.5M4%
Total Debt13.8M898K1,537%
FUNDAMENTALS RATINGS
AIMD vs MBOT: Fundamental Ratings
AIMD
MBOT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
6381
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MBOT's Valuation (36) in the Biotechnology industry is somewhat better than the same rating for AIMD (88) in the null industry. This means that MBOT’s stock grew somewhat faster than AIMD’s over the last 12 months.

MBOT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AIMD (100) in the null industry. This means that MBOT’s stock grew similarly to AIMD’s over the last 12 months.

MBOT's SMR Rating (97) in the Biotechnology industry is in the same range as AIMD (99) in the null industry. This means that MBOT’s stock grew similarly to AIMD’s over the last 12 months.

AIMD's Price Growth Rating (63) in the null industry is in the same range as MBOT (81) in the Biotechnology industry. This means that AIMD’s stock grew similarly to MBOT’s over the last 12 months.

AIMD's P/E Growth Rating (100) in the null industry is in the same range as MBOT (100) in the Biotechnology industry. This means that AIMD’s stock grew similarly to MBOT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AIMDMBOT
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 19 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
87%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AIMD
Daily Signal:
Gain/Loss:
MBOT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MENS2.180.02
+0.93%
Jyong Biotech Ltd
LZMH1.130.01
+0.89%
LZ Technology Holdings Limited
NTAP192.27-0.54
-0.28%
NetApp
FDMT15.83-0.27
-1.68%
4D Molecular Therapeutics
MANE102.82-2.50
-2.37%
Veradermics Inc

MBOT and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBOT has been loosely correlated with AGPU. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MBOT jumps, then AGPU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
+0.67%
AGPU - MBOT
37%
Loosely correlated
-4.49%
RCEL - MBOT
33%
Poorly correlated
-0.30%
AIMD - MBOT
32%
Poorly correlated
-1.38%
CODX - MBOT
31%
Poorly correlated
+5.22%
NNOX - MBOT
30%
Poorly correlated
-2.84%
More